Optimization and Characterization of Quercetin Vitamin C Nano-Phytosome Formulation

Abstract

Objective: To design an optimal formulation for quercetin and vitamin C nano-phytosome.
 Methods: Nano-phytosomes are prepared by the thin layer hydration technique using a 2-level-5-factor design experimental. A total of 32 experimental formulas were used for data analysis. The ratio of quercetin: soy lecithin (X1), the ratio of quercetin: cholesterol (X2), stirring speed (X3), stirring temperature (X4), and stirring time (X5) were used as independent factors, while globule size as a dependent factor. Data analysis was carried out by Design Expert12® application. Characterization of the optimal formula included physicochemical evaluation, globule size analysis, zeta potential, polydispersity index, entrapment efficiency, Transition Electron Microscopy (TEM) analysis, and FTIR analysis.
 Results: The optimal formula consisted of quercetin: vitamin C: lecithin: cholesterol ratio of 1: 1: 1.046: 0.105 mol; stirring speed 763.986 rpm; stirring time of 59 min, at temperature 51.73 °C which produced 59.26 nm average globule size, PDI value 0.66; zeta potential value-35.93±0.95 mV and average SPAN value 0.61. This formulation showed entrapment efficiency of quercetin 91.69±0.18 % and vitamin C 90.82±0.13 %. The TEM and FITR analysis showed the morphological of the globules and interactions between the drugs, soy lecithin, and cholesterol to form nano-phytosomes.
 Conclusion: The conditions to obtain the optimal formula for quercetin vitamin C nano-phytosome consisted of quercetin: vitamin C: lecithin: cholesterol ratio of 1: 1: 1.046: 0.105 mol; stirring speed 763.986 rpm; stirring time of 59 min, and at temperature 51.73 °C

Nanotope™ sebagai Sistem penghantaran Cosmeceutical untuk Meningkatkan Intensitas Efek pada Kulit

“…Hal ini menyebabkan rendahnya bioavabilitas kuersetin. Quersetin ditinjau dari aktifitas farmakologisnya memiliki beberapa efek seperti antiinflamasi, antibakteri, antioksidan, dan anti aging (Nandayasa et al, 2023).…”